kabutan

Techno Medica to abolish shareholder benefit program

Tue Jun 2, 2026 5:14 pm JST Catalyst

Techno Medica Co., Ltd. <6678> said on June 2 that it will abolish its shareholder benefit program as of the Sept. 30, 2026 record date. Following deliberations on fair profit distribution, the company decided to scrap the program and focus on stable and equitable dividend returns. Having updated its dividend policy on May 11, the company targets a dividend payout ratio of 80% or more and a total return ratio of 150% under its medium-term management plan through the fiscal year ending March 2029.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles